Key data
| Regulation | Royal Decree-Law 40/2026, of November 20, on urgent measures to promote competitiveness and technological sovereignty in the scientific and research field |
|---|---|
| Publication | November 21, 2026 |
| Entry into force | November 21, 2026 |
| Affected parties | Public research centers, universities and companies with R&D+i activities |
| Category | Education / Technology / Business taxation |
| Fiscal year | 2026 (maximum validity of special status: 10 years) |
| R&D investment Spain vs EU | 1.5% of GDP (Spain) versus 2.2% of GDP (EU average) |
| Control body created | Interministerial Commission CICTIAP |
Companies that invest in R&D+i in Spain have had an additional lever since November 21, 2026: the Royal Decree-Law 40/2026 strengthens the legal certainty of tax deductions for research and development and technological innovation, reducing the uncertainty that has historically hindered private investment in this field. The regulation is published in a clear context: Spain invests 1.5% of GDP in R&D, compared to 2.2% on average in the EU, a gap that the Government seeks to close with this package of measures.
What does this regulation establish?
RDL 40/2026 acts on two differentiated fronts: the public research sector and private companies with R&D+i activities.
For the public sector: a special status is created applicable to a maximum of 20 public research centers working in technologies considered critical. Centers declared under this regime are exempt from:
- Public employment limitations (they can hire more agilely).
- Centralized procurement (they can manage their purchases autonomously).
- Ordinary bidding thresholds (greater flexibility in contracts).
Furthermore, these centers will be able to directly transfer research rights under private law and participate as a minority partner in commercial companies without being subject to the usual asset management regulations.
The critical technologies covered by the special status are:
| Critical technology |
|---|
| Artificial Intelligence (AI) |
| Semiconductors |
| Biotechnology |
| Quantum computing |
The control and evaluation of these centers falls to the Interministerial Commission CICTIAP, created expressly by this regulation. The declaration of special status has a maximum validity of 10 years.
For private companies: the regulation increases the legal certainty of tax deductions for R&D and technological innovation. This means that companies applying these deductions in their Corporate Income Tax return now have a more solid framework against possible reviews by the Tax Agency.
Economic and operational impact
For companies, the most immediate impact is the reduction of tax risk associated with R&D+i deductions. Historically, uncertainty about whether the Tax Agency would accept certain activities as R&D has discouraged many companies from applying these deductions or investing more. A more solid legal framework has a direct effect: more companies will apply deductions with confidence, reducing their effective tax burden.
For public research centers, the elimination of bureaucratic obstacles represents a significant operational advantage: they can hire talent faster, manage their purchases with agility and collaborate with the private sector through transfer of rights and corporate participation without the usual constraints of public asset management regulations.
The stated objective of the regulation is to reduce the investment gap between Spain and the European average: moving from 1.5% to 2.2% of GDP in R&D investment requires both private tax incentives and public capacity to attract and retain research talent.
Who does it affect?
- Companies with R&D+i activities that apply or plan to apply tax deductions in Corporate Income Tax.
- CFOs and financial directors who manage tax planning for technology, pharmaceutical, industrial or any sector with research investment companies.
- Public research centers working in AI, semiconductors, biotechnology or quantum computing and aspiring to special status.
- Universities with research activity in critical technologies.
- Tax advisors and consultants who accompany companies in managing R&D+i tax incentives.
- Technology startups and scale-ups developing projects in the four critical technologies defined.
Practical example
A software company based in Spain invests 2 million euros annually in developing an artificial intelligence system for logistics optimization. Until now, its tax team was unsure whether to apply the R&D deduction (which can reach 25-42% of expenses, according to Corporate Income Tax regulations) for fear of an inspection that would question the classification of the activity.
With RDL 40/2026, the reinforced legal certainty framework reduces that risk. The CFO can apply the deduction with greater confidence, resulting in significant potential tax savings on the 2 million invested, without needing to provision additional tax contingencies for this item.
In parallel, if this company collaborates with one of the up to 20 public centers declared under special status, that center will be able to transfer research rights to it under private law and participate as a minority partner in the company, something that was previously blocked by public asset management regulations.
What should companies do now?
- Review current R&D+i activities and verify if they meet the requirements to apply tax deductions in Corporate Income Tax, taking advantage of the new framework of greater legal certainty.
- Consult with the tax advisor the specific impact of the reinforced legal certainty on deductions already applied or pending application in fiscal year 2026.
- Identify if there is potential collaboration with any of the public research centers that may be declared under special status (technologies: AI, semiconductors, biotechnology, quantum).
- Properly document R&D+i projects: reinforced legal certainty does not eliminate the need for solid technical and economic documentation to justify deductions before the Tax Agency.
- Follow the activity of the Interministerial Commission CICTIAP to learn which centers are declared under special status and evaluate public-private collaboration opportunities.
Frequently asked questions
What R&D+i tax deductions does RDL 40/2026 strengthen?
The regulation increases the legal certainty of tax deductions for R&D and technological innovation in Corporate Income Tax. It does not create new deductions, but rather consolidates the legal framework so that companies can apply existing ones with less risk of contingencies in Tax Agency inspections.
How many centers can obtain special status and in what technologies?
Special status can be granted to a maximum of 20 public research centers working in critical technologies: artificial intelligence, semiconductors, biotechnology and quantum computing. The maximum validity of this status is 10 years.
What specific advantages do centers declared under special status have?
They are exempt from public employment limitations, centralized procurement and ordinary bidding thresholds. Additionally, they can transfer research rights under private law and participate as a minority partner in commercial companies without being subject to the usual public asset management regulations.
When did RDL 40/2026 enter into force?
Royal Decree-Law 40/2026 entered into force on the same day of its publication in the Official Gazette: November 21, 2026.
What is the Interministerial Commission CICTIAP?
It is the body created by RDL 40/2026 to evaluate and control public research centers that request or have obtained special status. Its function is to ensure that declared centers meet the requirements and objectives provided for in the regulation.
Official source
Consult complete regulation in official source
Notice: This article is merely informative in nature and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://www.boe.es/diario_boe/txt.php?id=BOE-A-2026-24437